Quest Diagnostics
$16.01 B
Share price
Change (1 day)
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) Fails to deliver data

Key failure to deliver metrics for Quest Diagnostics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Quest Diagnostics (DGX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Quest Diagnostics (DGX) - since 2013

Volume in USD (price x number of shares), data since 2013

Quest Diagnostics (DGX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$6.93 M-85.82%
2023$48.92 M75.65%
2022$27.85 M-61.47%
2021$72.29 M119.6%
2020$32.92 M-59.04%
2019$80.37 M47.27%
2018$54.57 M197.07%
2017$18.37 M-60.99%
2016$47.09 M14.17%
2015$41.25 M-56.86%
2014$95.62 M66.88%
2013$57.3 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.01 M$44 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.01 M$0.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
$3.69 M$8.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.01 M$0.53 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.05 M$13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/A$67.9 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands